Impact of tixagevimab/cilgavimab prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplants and CAR T-cell therapy: a single center experience.

Detalles Bibliográficos
Autores principales: Xue, Elisabetta, Scorpio, Gianluca, Ruggeri, Annalisa, Clerici, Daniela, Farina, Francesca, Campodonico, Edoardo, Acerbis, Andrea, Fiore, Paolo, Bruno, Alessandro, Carrabba, Matteo G, Peccatori, Jacopo, Greco, Raffaella, Stanghellini, Maria Teresa Lupo, Ciceri, Fabio, Corti, Consuelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Masson SAS. 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299847/
https://www.ncbi.nlm.nih.gov/pubmed/37399601
http://dx.doi.org/10.1016/j.retram.2023.103402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299847/
https://www.ncbi.nlm.nih.gov/pubmed/37399601
http://dx.doi.org/10.1016/j.retram.2023.103402

Ejemplares similares